Vanguard Group Inc Precigen, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,330,491 shares of PGEN stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,330,491
Previous 8,328,141
0.03%
Holding current value
$14.6 Million
Previous $7.91 Million
17.94%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PGEN
# of Institutions
144Shares Held
160MCall Options Held
136KPut Options Held
4.8K-
Third Security, LLC83.5MShares$146 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$31.3 Million1.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$19 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$17.9 Million0.0% of portfolio
-
Iridian Asset Management LLC5.24MShares$9.17 Million1.64% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $364M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...